Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.
Several pieces of evidence suggest that small RNA degradation products together with tRNase ZL appear to form another layer of the whole gene regulatory network. The degraded RNA such as a 5'-half-tRNA and an rRNA fragment function as small guide RNA (sgRNA) to guide the enzyme to target RNA. W...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4346264?pdf=render |
_version_ | 1817990231926767616 |
---|---|
author | Sho Ninomiya Mitsuoki Kawano Takashi Abe Tatsuya Ishikawa Masayuki Takahashi Masato Tamura Yoshiaki Takahashi Masayuki Nashimoto |
author_facet | Sho Ninomiya Mitsuoki Kawano Takashi Abe Tatsuya Ishikawa Masayuki Takahashi Masato Tamura Yoshiaki Takahashi Masayuki Nashimoto |
author_sort | Sho Ninomiya |
collection | DOAJ |
description | Several pieces of evidence suggest that small RNA degradation products together with tRNase ZL appear to form another layer of the whole gene regulatory network. The degraded RNA such as a 5'-half-tRNA and an rRNA fragment function as small guide RNA (sgRNA) to guide the enzyme to target RNA. We were curious whether there exist RNAs in plasma that can function as sgRNAs for tRNase ZL, whether these RNAs are working as signaling molecules between cells to fulfill physiological roles, and whether there are any differences in plasma sgRNA species and levels between normal and pathological conditions. Here, we analyzed small plasma RNAs from three healthy persons and three multiple myeloma patients for potential sgRNAs by deep sequencing. We also examined small RNAs from peripheral blood mononuclear cells (PBMC) of three healthy persons and three myeloma patients and from various cultured human cell lines for sgRNAs. We found that read-number distribution patterns of plasma and PBMC RNAs differ between persons in the range of 5-40 nt and that there are many RNA species that exist significantly more or less abundantly in the plasma or PBMC of the myeloma patients than those of the healthy persons. Furthermore, we found that there are many potential sgRNAs in the 5-40-nt RNAs and that, among them, a 31-nt RNA fragment derived from 94-nt Y4-RNA, which can function as a 5'-half-tRNA-type sgRNA, is overwhelmingly abundant in the plasma of 2/3 of the examinees. These observations suggest that the gene regulatory network via tRNase ZL and sgRNA may be extended intercellularly. |
first_indexed | 2024-04-14T00:56:46Z |
format | Article |
id | doaj.art-e7c71fe80c5144bb964bd4368b79c4f0 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-14T00:56:46Z |
publishDate | 2015-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-e7c71fe80c5144bb964bd4368b79c4f02022-12-22T02:21:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011863110.1371/journal.pone.0118631Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.Sho NinomiyaMitsuoki KawanoTakashi AbeTatsuya IshikawaMasayuki TakahashiMasato TamuraYoshiaki TakahashiMasayuki NashimotoSeveral pieces of evidence suggest that small RNA degradation products together with tRNase ZL appear to form another layer of the whole gene regulatory network. The degraded RNA such as a 5'-half-tRNA and an rRNA fragment function as small guide RNA (sgRNA) to guide the enzyme to target RNA. We were curious whether there exist RNAs in plasma that can function as sgRNAs for tRNase ZL, whether these RNAs are working as signaling molecules between cells to fulfill physiological roles, and whether there are any differences in plasma sgRNA species and levels between normal and pathological conditions. Here, we analyzed small plasma RNAs from three healthy persons and three multiple myeloma patients for potential sgRNAs by deep sequencing. We also examined small RNAs from peripheral blood mononuclear cells (PBMC) of three healthy persons and three myeloma patients and from various cultured human cell lines for sgRNAs. We found that read-number distribution patterns of plasma and PBMC RNAs differ between persons in the range of 5-40 nt and that there are many RNA species that exist significantly more or less abundantly in the plasma or PBMC of the myeloma patients than those of the healthy persons. Furthermore, we found that there are many potential sgRNAs in the 5-40-nt RNAs and that, among them, a 31-nt RNA fragment derived from 94-nt Y4-RNA, which can function as a 5'-half-tRNA-type sgRNA, is overwhelmingly abundant in the plasma of 2/3 of the examinees. These observations suggest that the gene regulatory network via tRNase ZL and sgRNA may be extended intercellularly.http://europepmc.org/articles/PMC4346264?pdf=render |
spellingShingle | Sho Ninomiya Mitsuoki Kawano Takashi Abe Tatsuya Ishikawa Masayuki Takahashi Masato Tamura Yoshiaki Takahashi Masayuki Nashimoto Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines. PLoS ONE |
title | Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines. |
title_full | Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines. |
title_fullStr | Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines. |
title_full_unstemmed | Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines. |
title_short | Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines. |
title_sort | potential small guide rnas for trnase zl from human plasma peripheral blood mononuclear cells and cultured cell lines |
url | http://europepmc.org/articles/PMC4346264?pdf=render |
work_keys_str_mv | AT shoninomiya potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines AT mitsuokikawano potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines AT takashiabe potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines AT tatsuyaishikawa potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines AT masayukitakahashi potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines AT masatotamura potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines AT yoshiakitakahashi potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines AT masayukinashimoto potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines |